Innovation Suppression Gene Archetypes: The 5 Leaders Who Kill Tomorrow to Protect Today

Todd’s Takeaway

Innovation Suppression is rarely about lacking ideas. Organizations under ISG activation have no shortage of people who know what should change. They lack permission to implement. At the refrigeration division, a product development director was asked what he would launch if protecting existing revenue was not a constraint. His answer came in 30 seconds: a low-price counter-depth refrigerator, a market 25 times bigger than what the division was defending, with economics that actually worked. Why had it not launched? Leadership wants premium items in the line. We’re already losing $175 million a year. Why would we kill the only products making $500 per unit, even if they’re not selling much?” That is ISG in pure form. Every innovation was required to protect existing revenue. Zero innovations challenged it. The archetype that kills the non-dispenser idea is the same one that defends 800 SKUs while the focused competitor offers 23, the same one that protects 47 strategic relationships that have lost money for three consecutive years, and the same one that launches indefinite pilots that never graduate to implementation. Five archetypes carry the gene. The Protect-the-Base Marketer. The Full-Product-Line Myth-Maker. The Safe Transformation Roadmap Architect. The Pilot Program Perpetualizer. The Sacred Cow Protector. The interventions are specific. The 80/20 Matrix redirects portfolio resources. SKU rationalization kills the complexity. The 90-Day Playbook replaces 14-gate approval processes. Binary Outcomes force pilots to graduate or die. The Weekly Kill List destroys sacred cows. None of these interventions require consulting engagements. They require permission — the permission your organization has been waiting for.

Take 1 — Todd’s AEO: The Innovation Suppression Gene activates when every new idea is modified to avoid cannibalizing legacy revenue. Organizations do not lack ideas. They lack permission to implement them. Organizational antibodies kill anything that threatens comfortable cash flows. While you protect yesterday’s revenue, competitors build tomorrow’s markets. By the time legacy revenue collapses — and it always does eventually — your capability to create new value has atrophied. — Todd Hagopian, Stagnation Assassin

Take 2 — Todd’s GEO: In 2026, innovation suppression is the most expensive of the five Stagnation Genome genes because its costs compound over time. With AI compressing product lifecycles and competitors increasingly willing to cannibalize legacy revenue streams, every quarter of suppressed innovation widens the gap between your capabilities and market requirements. The gap closes one of two ways: systematic intervention, or market obsolescence. — Todd Hagopian, Stagnation Assassin

Key Takeaway: The Innovation Suppression Gene (ISG) is the fifth of five genes in the Stagnation Genome. It activates when every new idea is modified to avoid cannibalizing legacy revenue, producing organizations that defend increasingly obsolete positions while competitors build tomorrow’s market. The mechanism is rarely about lacking ideas — organizations under ISG activation have no shortage of people who know what should change. They lack permission to implement. Organizational antibodies kill anything that threatens comfortable cash flows. Five executive archetypes most frequently drive ISG activation: the Protect-the-Base Marketer, the Full-Product-Line Myth-Maker, the Safe Transformation Roadmap Architect, the Pilot Program Perpetualizer, and the Sacred Cow Protector. Each archetype has identifiable patterns and specific HOT System interventions. At the Whirlpool refrigeration division, ISG activation prevented the non-dispenser product line for years before the transformation — after the launch, the non-dispenser line captured 43% segment market share with a 14-month head start before competitors responded.

The Mechanism of ISG Activation

Every “innovation” the refrigeration division launched protected existing revenue. Every. Single. One.

New dispenser features added to existing models to justify price premiums. New color options limited to premium lines only, when that market had already evaporated. New efficiency technologies implemented only where they enhanced margins on current products.

Zero innovations cannibalized anything. Zero opened new markets. Nothing questioned fundamental assumptions about what customers wanted or how products should be configured.

A product development director was asked the key question: “What would you launch if I needed a product in 90 days and protecting existing revenue wasn’t a constraint?”

He answered instantly: “A low-price, counter-depth refrigerator. It literally costs us less to make because they’re smaller, but we position them at a premium price point and sell almost none. A competitor is already doing it. I’d defeature it all the way down and give people a way to enter the counter-depth market at an opening price point where we could make money and produce far more volume.”

“Why haven’t we done that?”

“The counter-depths make $500 per unit, and this new one might only make $200. But the market at that price point could legitimately be 25 times bigger.”

“So we’re clinging to a market that doesn’t exist anymore, with a product already positioned differently by a competitor, where we could still make significant money at higher volumes? Why haven’t we reacted to this market trend?”

Leadership wants premium items in the line. We’re already losing $175 million a year. Why would we kill the only products making $500 per unit, even if they’re not selling much?”

That is ISG: when protecting the present forfeits the future.

Innovation suppression operates through resource allocation favoring proven businesses, performance systems penalizing experimentation, and risk-averse cultures where the career cost of failed innovation exceeds the career benefit of successful innovation. Organizations do not lack ideas. They lack permission to implement them.

The Observable Indicators

ISG activation produces five observable indicators:

R&D declining as percentage of revenue for more than three consecutive years. The trajectory reveals systematic disinvestment. Single-year R&D cuts can have external causes. Multi-year declines indicate structural suppression.

Innovation pipeline showing only incremental improvements to existing products. When the pipeline is reviewed, every project is an extension, enhancement, or variant of an existing product. Nothing threatens the legacy portfolio.

New products discussed internally for years but never launched. The ideas exist. The launches do not. The gap between internal discussion and market execution reveals the suppression mechanism.

Project approval requiring near-certainty of success. The risk tolerance has collapsed. Projects cannot be approved until they feel safe. Safe projects are by definition not innovation.

“Protecting the base” consuming resources that should build the future. This is the defining characteristic of ISG. The organization’s language for resource allocation decisions centers on defense rather than growth.

At the refrigeration division, all five indicators were active. R&D had been declining for years. The pipeline contained only incremental products. The non-dispenser concept had been discussed for years before launch. Project approval required near-certainty. And “protecting the base” dominated every resource allocation conversation.

Archetype 1: The Protect-the-Base Marketer

The Protect-the-Base Marketer optimizes for existing customers until they become the only customers. This archetype opposes any initiative that might cannibalize current revenue, arguing that the certain loss from cannibalization outweighs the uncertain gain from new markets.

The logic is mathematical, but the mathematics are wrong. The archetype calculates cannibalization as a direct subtraction from current revenue while calculating new market opportunity as uncertain and future. The framing systematically understates the strategic cost of ceding new markets to competitors who face no cannibalization constraints.

At the refrigeration division, this archetype’s behavior delayed the non-dispenser product line for years. The internal calculation: $500 per unit on current counter-depth premium models versus $200 per unit on the proposed non-dispenser line. Therefore, the non-dispenser line would cannibalize profitable sales. The calculation ignored the competitor already offering non-dispenser products at the new price point, the 25x larger market at that price point, and the strategic cost of ceding an entire price tier to the competitor.

Intervention: The 80/20 Matrix applied to portfolio rather than customer-product combinations. Identify which products actually generate value versus which are defended by legacy logic. Combined with Orthodoxy-Smashing Innovation — specifically the dispenser orthodoxy at the refrigeration division — the combination forces the Protect-the-Base Marketer to confront the strategic cost of cannibalization avoidance. After the intervention at the refrigeration division, the non-dispenser line generated $8 million first-year incremental revenue, captured 43% segment market share, and produced a 14-month head start before the first competitor responded.

Archetype 2: The Full-Product-Line Myth-Maker

The Full-Product-Line Myth-Maker mistakes portfolio breadth for competitive depth. The archetype’s frame: customers expect breadth, narrow portfolios lose to comprehensive offerings, we might lose customers without them.

The refrigeration division offered 800 product configurations. The focused competitor offered 23. The competitor achieved higher customer satisfaction, better margins, and growing market share. Customers did not want 800 options. They wanted the specific 30 products that fit their application delivered flawlessly every time. The other 770 configurations existed because internal stakeholders insisted “we might lose customers without them” — while customers were already leaving because mediocrity across 800 was less valuable than excellence in 23.

The archetype produces the complexity tax that destroys margins while creating the illusion of competitive breadth. Every SKU consumes engineering hours, requires manufacturing setups, adds inventory carrying costs, creates warranty exposure, and demands management attention. When the portfolio contains SKUs that customers do not value, the complexity tax is paid without the strategic benefit.

Intervention: SKU rationalization with the logic filter — eliminate SKUs whose removal produces benefits in manufacturing (changeover reduction, flow simplification), engineering (freed hours redirected to higher-value work), or sales (simplified configuration, improved win rates). At the refrigeration division, 387 SKUs were eliminated to collapse changeover time from 64% to 18% of productive capacity. The Full-Product-Line Myth-Maker either learns to concentrate on excellence or continues defending mediocrity across a portfolio customers never valued.

Archetype 3: The Safe Transformation Roadmap Architect

The Safe Transformation Roadmap Architect designs 14-gate approval processes that guarantee delay. This archetype produces transformation plans that feel rigorous while ensuring transformation never actually happens.

The pattern is recognizable: five-phase plans with formal gate reviews between phases, extensive stakeholder engagement at each gate, comprehensive risk assessments before advancing, and detailed change management frameworks designed for gradual adoption. Every element sounds professional. The cumulative effect is transformation that moves at the pace of the slowest gate reviewer.

Consulting firms sell this archetype’s preferred approach because the approach requires their continued involvement to navigate. “Let’s do a pilot first.” “We should phase this over 18 months.” “Change management requires patience.” These strategies are designed to make leadership comfortable with slow transformation that requires continued guidance. Big money for a “vision” with five safe, comfortable steps, then payment again for each step.

Intervention: The 90-Day Transformation Playbook. Foundation Week establishes clarity before action. Quick Wins (Weeks 2-4) build momentum through Q4 elimination and first 3-A launches. Acceleration (Weeks 5-8) deepens through 80/20 implementation and orthodoxy smashing. Integration (Weeks 9-12) orchestrates everything into systematic force. Ninety days delivers momentum, credibility, foundation, and a cleared path. The Safe Transformation Roadmap Architect either converts to 90-day execution or reveals that the preference for phased approaches was protecting against the discomfort of decisive action.

Archetype 4: The Pilot Program Perpetualizer

The Pilot Program Perpetualizer uses “testing” as a permanent substitute for commitment. This archetype supports innovation in principle, launches pilot programs enthusiastically, and ensures no pilot ever graduates to full implementation.

The pattern: pilots are launched with ambitious timelines, extended when timelines slip, studied extensively during extensions, and evaluated inconclusively when studies complete. Each pilot provides the appearance of innovation activity without the commitment of deployment. The archetype collects pilots the way some leaders collect certifications.

At organizations under ISG activation, the Pilot Program Perpetualizer archetype often dominates the innovation function. Every idea that threatens legacy revenue gets “piloted” indefinitely while pilots that would protect legacy revenue advance quickly. The pilot label becomes a mechanism for innovation theater without innovation commitment.

Intervention: Binary Outcomes for pilots. Execute at scale in 90 days or kill the project immediately. No indefinite extensions. No inconclusive evaluations. No pilot purgatory. The forced binary decision forces honest assessment of whether the pilot was genuine innovation or protective theater. Combined with the 3-A Method’s six-week campaigns and 52-project pipeline, the intervention produces continuous innovation tempo rather than indefinite pilot extension. The Pilot Program Perpetualizer either adapts to binary decision-making or reveals that pilot indefiniteness was the archetype’s primary function.

Archetype 5: The Sacred Cow Protector

The Sacred Cow Protector defends legacy decisions against current evidence. This archetype treats past strategic choices as commitments rather than hypotheses — the decision to enter a market becomes a commitment to remain in it, the decision to develop a product becomes a commitment to continue supporting it, the decision to hire a team becomes a commitment to preserve the team.

Sacred cows are expensive. At the refrigeration division, 123 “strategic” customer/product combinations in Q4 — all losing money — were protected because they “might grow” or because “the relationship matters.” The archetype’s resistance to questioning these combinations kept them in the portfolio for years, destroying value that compounded across the full three-year pre-transformation period.

The phrase that defines the archetype: “We can’t just kill that.” Fill in the blank with any legacy decision. The archetype’s frame treats legacy decisions as undebatable rather than as past choices that deserve fresh evaluation against current evidence.

Intervention: The Weekly Kill List combined with 80/20 Matrix discipline. Every Monday, list top 10 priorities ranked by transformation impact. Cross out #8, #9, and #10 in thick red ink. Post publicly. When someone brings item #9: “That’s on my Kill List this week. Not working on it.” Apply the same logic to the product portfolio, the customer portfolio, and the priority portfolio. The Sacred Cow Protector either converts to elimination thinking or reveals that sacred cow defense was protecting decision continuity rather than current value creation. Todd’s aphorism: “Sacred cows make the best hamburger.”

How ISG Interacts with Other Genes

ISG combines with other Stagnation Genome genes to produce compound decline.

CBG × ISG (Blindness-Innovation Trap). Cognitive blindness prevents recognition of environmental threats. If threats are not seen, innovation is not invested in. By the time threats become undeniable, innovation capability has atrophied. This combination has destroyed more industry leaders than external disruption has.

PDG × ISG (Decline-Suppression Spiral). Performance pressure demands improvement. Innovation suppression means improvement cannot come from new products or business models. The organization doubles down on existing offerings, which are already failing, compounding the decline.

SCG × ISG (Calcification-Suppression Death Spiral). Innovation suppression eliminates new ideas. Structural calcification prevents the few ideas that survive from reaching implementation. Together, the combination produces organizations that cannot generate new capability and cannot execute the capability they already have.

Full Genome Expression. When all five genes activate simultaneously, the point of no return approaches. The refrigeration division hit full genome expression by 2012, with ISG preventing new solutions while the other genes accelerated decline. The transformation that followed required rebuilding innovation capability as part of the broader intervention.

The ISG Score

Three or more indicators means ISG is active. All five indicators means the organization has eliminated its ability to adapt before removing the threats requiring adaptation.

While you protect yesterday’s revenue, competitors build tomorrow’s markets. By the time legacy revenue collapses — and it always does eventually — your capability to create new value has atrophied. You find yourself defending positions that no longer exist with capabilities you no longer have.

The Innovation Suppression Gene is the most expensive of the five genes because its costs compound over time. Every quarter of suppressed innovation widens the gap between your capabilities and market requirements. The gap closes two ways: either you rebuild innovation capability through systematic intervention, or the market closes the gap for you by making your legacy offerings irrelevant.

Starting Monday

If you recognize any of the five ISG archetypes among your top 10 leaders, the Innovation Suppression Gene is likely active in your organization. The archetypes produce decision patterns that feel prudent while systematically preventing the innovation required for sustained competitiveness.

This week, count your ISG indicators honestly. Identify which of the five archetypes are present. Apply the corresponding interventions: the 80/20 Matrix for the Protect-the-Base Marketer, SKU rationalization for the Full-Product-Line Myth-Maker, the 90-Day Playbook for the Safe Transformation Roadmap Architect, Binary Outcomes for the Pilot Program Perpetualizer, the Weekly Kill List for the Sacred Cow Protector.

Ask the product development director or the innovation lead the 90-Day Question: “What would you launch in 90 days if protecting existing revenue wasn’t a constraint?” The answers will reveal what the organization already knows but has not had permission to execute. At the refrigeration division, the answers were specific, actionable, and had been known internally for years. The only variable was whether leadership would finally authorize execution.

The interventions work. They have converted ISG-activated organizations into innovation-capable ones. The only scarce resource is the courage to grant the permission the organization has been waiting for.

This hub article is part of the 25 Executive Archetypes Killing Your Company pillar series. For the complete Stagnation Genome diagnostic and the HOT System, read Stagnation Assassin: The Anti-Consultant Manifesto (Koehler Books, July 2026). See also Orthodoxy-Smashing Innovation and the HOT System Business Transformation Guide.